Page last updated: 2024-10-28

hydroxychloroquine and Cerebral Infarction, Middle Cerebral Artery

hydroxychloroquine has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Valderrama, EV1
Humbert, K1
Lord, A1
Frontera, J1
Yaghi, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Long-term Neurocognitive and Psychiatric Consequences of COVID-19 in Patients Discharged From Critical Care Units. A Cohort Study of the Advance Interdisciplinary Rehabilitation Register (AIRR) Covid-19 Working Group.[NCT05019300]80 participants (Anticipated)Observational2021-05-24Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for hydroxychloroquine and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke.
    Stroke, 2020, Volume: 51, Issue:7

    Topics: Betacoronavirus; Carotid Artery, Internal; Carotid Stenosis; Cerebral Angiography; Clinical Laborato

2020
chemdatabank.com